Organization
UC Davis Medical Center
1 abstract
Abstract
A phase I/II study of enzalutamide in combination with indomethacin in men with castration-resistant prostate cancer (CRPC).Org: UC Davis Department of Internal Medicine, UC Davis Medical Center, Department of Medicine, Brigham and Women’s Hospital,